lebrikizumab-lbkz

FDA Drug Profile — EBGLYSS

lebrikizumab-lbkz is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including EBGLYSS. Available dosage form: injection, solution.

Drug details

Generic Name
lebrikizumab-lbkz
Brand Names
EBGLYSS
Application Number
BLA761306
Sponsor
Eli Lilly And Company
NDC Codes
4
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
LEBRIKIZUMAB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.